Localized Severe Scleroderma: A Retrospective Study of 26 Pediatric Patients.
Correlation between various treatments and clinical endpoint showed that systemic therapy lead to a better outcome: in particular, methotrexate appeared the most effective drug, capable in halting the progression of the disease and sometimes inducing its regression. M Beltramelli.(PubMed) Pediatr Dermatol. 2010 Aug 26. (Also see: Treatments for Juvenile Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Localized Severe Scleroderma: A Retrospective Study of 26 Pediatric Patients
No replies to this topic